Article
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.
Frontiers in immunology - 1 Jan 2026
Morelli Martina, Scaglione Giovanni Luca, Dattolo Anna, Galluzzo Marco, Scarponi Claudia, Moretta Gaia, Provini Alessia, Russo Filomena, Cocuroccia Barbara, Sordi Donatella, Talamonti Marina, Villella Valeria, Selvi Fabio Romano, Mercurio Laura, Paganini Claudia, Mortato Edoardo, Bianchi Luca, De Pità Ornella, Pallotta Sabatino, Scala Enrico, Albanesi Cristina, Madonna Stefania
Abstract excerpt
Background: Atopic dermatitis (AD) is a clinically heterogeneous immune-mediated skin disorder. The lack of reliable clinical stratification tools and predictive biomarkers for therapeutic response remains a critical unmet need to optimize treatment and advance precision dermatology. Objective: To investigate the association between genetic variants and AD phenotypes and response to Dupilumab as a potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
